Apyx Medical Corp
APYX- Exchange
- Nasdaq
- Industry
- Surgical & Medical Instruments & Apparatus
- SEC CIK
- 0000719135
No open-market purchases or sales by Apyx Medical Corp insiders were filed in the last 90 days; 67 institutions reported holding it in 13F filings for Q2 2026, worth $95.6M in total; no superinvestor holds it.
Q3 2023 vs. Q2 2023
How the institutions holding Apyx Medical Corp changed between Q2 2023 and Q3 2023.
All holders in Q3 2023All holders in Q2 2023
| Measure | Q2 2023 | Of which not filed for Q3 2023 | Q3 2023 | Change |
|---|---|---|---|---|
| Holders | 56 | 1 | 62 | +7 |
| Shares | 18.8M | 605.7K | 18.3M | +161.8K (+0.9%) |
| Value | $94.4M | $3.05M | $58.7M | −$32.7M (−35.8%) |
1 institution that held it in Q2 2023 haven't filed for Q3 2023 yet. Not filing isn't selling, so the changes leave them out.
New holders (18)
Institutions that held Apyx Medical Corp at the end of Q3 2023 but not at the end of Q2 2023.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Essex Investment Management Co LLC | 372,106 | $1.19M | 0.19% |
| Wealth Enhancement Advisory Services, LLC | 158,284 | $506.5K | 0.00% |
| Legato Capital Management LLC | 140,062 | $448.2K | 0.06% |
| Rathbone Brothers plc | 101,334 | $324.3K | 0.00% |
| Squarepoint Ops LLC | 78,262 | $250.4K | 0.00% |
| Trexquant Investment LP | 40,863 | $130.8K | 0.00% |
| Citigroup Inc | 38,277 | $122.5K | 0.00% |
| Caption Management, LLC | 23,956 | $76.7K | 0.01% |
| Royal Bank of Canada | 19,954 | $64.0K | 0.00% |
| American Century Companies Inc | 19,068 | $61.0K | 0.00% |
| Cubist Systematic Strategies, LLC | 17,126 | $54.8K | 0.00% |
| Algert Global LLC | 15,470 | $49.5K | 0.00% |
| Jump Financial, LLC | 15,000 | $48.0K | 0.00% |
| Barclays PLC | 14,284 | $45.7K | 0.00% |
| Qube Research & Technologies Ltd | 7,284 | $23.3K | 0.00% |
| Group One Trading, L.P. | 1,104 | $3.53K | 0.00% |
| BNP Paribas Arbitrage, SA | 15 | $48 | 0.00% |
| CWM, LLC | 117 | $0 | 0.00% |
Sold out (11)
Institutions that held Apyx Medical Corp at the end of Q2 2023 and filed for Q3 2023 without it.
| Institution | Shares, Q2 2023 | Value, Q2 2023 |
|---|---|---|
| EAM Investors, LLC | 251,896 | $1.27M |
| Gsa Capital Partners LLP | 41,593 | $209.0K |
| Boothbay Fund Management, LLC | 40,000 | $201.2K |
| Connor, Clark & Lunn Investment Management Ltd. | 16,945 | $85.2K |
| Verition Fund Management LLC | 13,400 | $67.4K |
| Jane Street Group, LLC | 12,745 | $64.1K |
| XTX Topco Ltd | 11,469 | $57.7K |
| Frisch Financial Group, Inc. | 10,431 | $52.0K |
| Kingsview Wealth Management, LLC | 10,017 | $50.4K |
| Creative Financial Designs Inc | 1,000 | $5.03K |
| Mather Group, LLC. | 1,000 | $5.03K |
Not filed for Q3 2023 yet (1)
Institutions that held Apyx Medical Corp at the end of Q2 2023 and haven't filed a 13F for Q3 2023. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q2 2023 | Value, Q2 2023 |
|---|---|---|
| Cowen Prime Advisors LLC | 605,682 | $3.05M |